6 May 17

Argon Medical Gadgets, Rex Medical announce licensing agreement for Cleaner Rotational Thrombectomy System Argon Medical Gadgets, Inc. Cleaner is certainly a medical device created for the mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts. Related StoriesBoehringer Ingelheim, Lilly announce option of Synjardy tablets in U.S. PharmaciesUT Southwestern evaluates allopurinol drug to avoid nephropathy in Type I diabetes patientsPatients with kidney failing at increased risk of developing different types of cancerArgon and Rex Medical will become exhibiting at the 34th Annual Getting together with of the Culture of Interventional Radiology to be held in Tampa, FL from March 14-17, 2008.The analysis achieved its primary endpoint demonstrating a statistically significant upsurge in progression-free of charge survival for enzalutamide compared with bicalutamide . Median PFS was 19.4 months in the enzalutamide group weighed against 5.7 months in the bicalutamide group. The median time on treatment in the STRIVE trial was 14.7 months in the enzalutamide group versus 8.4 months in the bicalutamide group. Serious adverse occasions were reported in 29.4 percent of enzalutamide-treated patients and 28.3 percent of bicalutamide-treated patients. Grade 3 or higher cardiac adverse occasions were reported in 5.1 percent of enzalutamide-treated sufferers versus 4.0 percent of bicalutamide-treated sufferers. One seizure was reported in the trial in the enzalutamide-treated group and none in the bicalutamide-treated group.